At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 265 enrolled
Drug / intervention
FE 999049 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multi-national, Multi-centre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Women Undergoing an ART Programme
In Brief
A Phase 2 clinical trial evaluating FE 999049 and Gonal - F for Infertility. Completed, enrolled 265 participants across 8 sites in 4 countries.
Detailed Summary
This trial investigates the effects of several doses of FE 999049 in women undergoing IVF/ICSI (in-vitro fertilisation/intracytoplasmic sperm injection) treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesBelgium, Czechia, Denmark, Spain
Collaborators--
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 2011
Enrollment StartSep 2011
Primary CompletionApr 2012
Study CompletionMar 2013
TodayJul 2026
First PostedAug 31, 2011
Enrollment StartSep 1, 2011
Primary CompletionApr 1, 2012
Study CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 14.8 years ago
Interventions
FE 999049drug
Gonal - Fdrug